Shixian Hua

发表

Pt(IV) hybrids containing a TDO inhibitor serve as potential anticancer immunomodulators.

S. Gou, Feihong Chen, Yuanjiang Wang, 2019, Journal of inorganic biochemistry.

Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues.

Ri-zhen Huang, S. Gou, Hengshan Wang, 2018, European journal of medicinal chemistry.

Glycyrrhetinic acid derivatives containing aminophosphonate ester species as multidrug resistance reversers that block the NF-κB pathway and cell proliferation.

Ri-zhen Huang, Bin Zhang, Hengshan Wang, 2018, Bioorganic & medicinal chemistry letters.

Multifunctional platinum(IV) complexes as immunostimulatory agents to promote cancer immunochemotherapy by inhibiting tryptophan-2,3-dioxygenase.

S. Gou, Feihong Chen, Gang Xu, 2019, European journal of medicinal chemistry.

Side chain-functionalized aniline-derived ursolic acid derivatives as multidrug resistance reversers that block the nuclear factor-kappa B (NF-κB) pathway and cell proliferation.

Z. Liao, Ri-zhen Huang, Hengshan Wang, 2017, MedChemComm.

The introduction of immunosuppressor (TDO inhibitor) significantly improved the efficacy of irinotecan in treating hepatocellular carcinoma

S. Gou, Feihong Chen, Xinyi Wang, 2020, Cancer Immunology, Immunotherapy.

Novel conjugates with dual suppression of glutathione S-transferases and tryptophan-2,3-dioxygenase activities for improving hepatocellular carcinoma therapy.

S. Gou, Feihong Chen, Xinyi Wang, 2019, Bioorganic chemistry.

Microtubule inhibitors containing immunostimulatory agents promote cancer immunochemotherapy by inhibiting tubulin polymerization and tryptophan-2,3-dioxygenase.

S. Gou, Feihong Chen, Shixian Hua, 2019, European journal of medicinal chemistry.

Dual-functional conjugates improving cancer immunochemotherapy by inhibiting tubulin polymerization and indoleamine-2,3-dioxygenase.

S. Gou, Feihong Chen, Xinyi Wang, 2020, European journal of medicinal chemistry.

Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.

Ri-zhen Huang, Hengshan Wang, Ying-Ming Pan, 2015, European journal of medicinal chemistry.

4-Methylumbelliferones Analogues as Anticancer Agents: Synthesis and in Cell Pharmacological Studies.

Ri-zhen Huang, Zhanling Ding, Hengshan Wang, 2017, Anti-cancer agents in medicinal chemistry.